FIGURE 1.
Cumulative incidence of rituximab-associated reverse seroconversion of HBsAg in 482 unvaccinated patients with CD20+ NHL, with death in the absence of reverse seroconversion of HBsAg as the competing risk.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.